Travel Bans & Travel Restrictions by Country/Region

From May 4, 2021, foreign nationals who have visited any of the following countries or regions within 14 days of their arrival in the United States are prohibited from entering: Austria, Belgium, Brazil, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Mainland China, Malta, Monaco, Netherlands, Norway, Poland, Portugal, San Marino, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Vatican City, and the United Kingdom. This policy provides limited exemptions for persons providing vital support for critical infrastructure, journalists, students, and certain academics covered by exchange visitor programs.

All persons traveling to the United States (including US nationals) must present proof of a negative result for COVID-19 issued no more than 3 days to departure using a nucleic acid or antigen test. Alternatively, persons who, at any point within 90 days of their scheduled departure for the United States, tested positive for COVID-19 may present "documentation of recovery" for travel to the United States. This must include proof of the positive test result along with a certificate from a recognized healthcare provider attesting that the traveler is not currently exhibiting symptoms consistent with COVID-19 is and cleared for travel. All travelers must additionally sign a form attesting that the information provided to airline staff is truthful and accurate to the best of the traveler's knowledge. Persons lacking such proof are prohibited from boarding flights bound for the United States. More information including post-travel recommendations is available via the following URL: https://www.cdc.gov/coronavirus/2019-ncov/travelers/testing-international-air-travelers.html

The United States government has mostly suspended the issuing of new visas and all US land border checkpoints with Canada and Mexico are closed to non-essential traffic. Additional restrictions are in place for persons holding special category visas including H-1B, H-2B, J-1, and L-1 visas. All travelers are encouraged to contact their local US embassy or consulate prior to finalizing travel arrangements. When arriving into or traveling within the United States, all persons must wear masks covering their mouth and nose while aboard any conveyance or at any transportation hub. Be advised, various state and local authorities in the United States have implemented additional policies and restrictions for persons arriving into their jurisdictions.

Foreign nationals traveling from Australia (except the State of Victoria), Brunei Darussalam, Mainland China (except Guangdong Province), or New Zealand are permitted to enter Singapore for short-term visits including for tourism. Travelers must apply for an "Air Travel Pass" (ATP) at least 7 days and no more than 30 days prior to their intended arrival in Singapore and must remain entirely within one of the permitted departure locations during the 21 days prior to their scheduled departure. Travelers applying for an ATP must have proof of medical insurance valid for use in Singapore for the entire duration of their stay. The minimum coverage amount must be no less than S$30,000. Upon arrival, travelers must, at their own expense, undergo a polymerase chain reaction (PCR) test for COVID-19 and self-isolate for 1-2 days at a pre-booked, non-residential accommodation while awaiting their test results. All persons (including Singapore nationals) who, within 21 days of their scheduled arrival, have visited the State of Victoria in Australia must undergo a PCR test upon arrival in Singapore, must self-isolate for 7 days at their place of residence, and must undergo an additional PCR test during the self-isolation period. All travelers are required to install the "TraceTogether" mobile app for contact tracing purposes and submit their personal information electronically via "SG Arrival Card" system. Travelers who hold a passport that requires a visa for travel to Singapore must separately obtain a valid visa prior to departure. An ATP is NOT a substitute for a required visa. More information including links to ATP applications are available at the following URL: https://safetravel.ica.gov.sg/arriving/overview

Business, official, and high economic value travelers from all countries and regions (with the exception India) are eligible to enter Singapore for short-term stays of up to 14 days. Travelers seeking to enter Singapore under the "Connect@Singapore initiative" must submit applications through an “Appointed Facility,” which will file an application on their behalf for a "Safe Travel Pass." Persons traveling under the Connect@Singapore initiative must present proof of a negative result for COVID-19 using a polymerase chain reaction (PCR) test prior boarding transportation bound for Singapore. For the entire duration of their stay, travelers will be required to stay within a "bubble" at Appointed Facilities, undergo regular PCR testing, and strictly observe all prevailing pandemic prevention and control measures. More information is available at the following URL: https://safetravel.ica.gov.sg/connectsg/overview

Residents from Brunei Darussalam and certain parts of Mainland China may be eligible to travel to Singapore for business or official travel using a so-called "Reciprocal Green Lane" (RGL) scheme. Persons seeking to use the RGL must be sponsored by either a Singapore-based company or a Singapore Government agency, which will file an application on their behalf for a "SafeTravel Pass." Once approved, "SafeTravel Pass" holders may then apply for a standard travel visa (persons holding existing valid visas need not apply for a new visa). Only residents from the following locations in Mainland China are eligible to use the RGL: Chongqing Municipality, Guangdong Province, Jiangsu Province, Shanghai Municipality, Tianjin Municipality, and Zhejiang Province. More information is available at the following URL: https://safetravel.ica.gov.sg/rgl/overview

Malaysian nationals and permanent residents holding valid Singapore work passes may be eligible for a new "Periodic Commuting Arrangement" (PCA) scheme allowing cross-border travel at the Johor-Singapore Causeway and Malaysia-Singapore Second Link. Singapore-based employers must submit an application to use the PCA on behalf of their employees. Applications must be submitted at least 7 days prior to the employee's intended entry into Singapore and employees must be willing to remain in Singapore for at least 90 days. Specific information requirements for submitting a PCA application are available at the following URL: https://safetravel.ica.gov.sg/pca/overview

From June 4, 2021, the following policies are in place:

1) All short-term visitors, regardless of origin, are prohibited from entering or transiting through Singapore;

2) Foreign nationals (including long-term pass holders) who, within 21 days or their scheduled departure, have visited or transited through Bangladesh, Nepal, Pakistan, or Sri Lanka are prohibited from entering Singapore;

3) All persons (including Singapore nationals) must, regardless of origin, undergo a polymerase chain reaction (PCR) test for COVID-19 upon arrival. Travelers must register and pre-pay for their on-arrival testing prior to departing for Singapore;

4) All persons (including Singapore nationals) authorized to travel to Singapore must carry proof of a negative result for COVID-19 issued no more than 72 hours prior to departure using a polymerase chain reaction (PCR) test. This policy does not apply to Singapore nationals and permanent residents traveling from Australia (except the State of Victoria), Brunei Darussalam, Hong Kong SAR, Macau SAR, Mainland China (except Guangdong Province), or New Zealand, provided such persons have remained entirely within one of those locations during the 21 days prior to their scheduled departure;

5) All persons (including Singapore nationals) will, depending on their travel history during the 21 days prior to their arrival, be directed to undergo some combination of self-isolation or quarantine at a designated facility for between 7 and 21 days. All persons are subject to additional PCR testing requirements at the end of their self-isolation or quarantine periods;

6) Foreign nationals holding a long-term pass issued by Immigration & Checkpoints Authority (ICA) must obtain prior permission from the relevant government agency prior to departing for Singapore. This includes Long-Term Visit Pass (LTVP) or Student's Pass (STP), or In-Principle Approval (IPA) letters for LTVP or STP.

All travelers are strongly encouraged to contact a local Singaporean embassy or consulate to verify their eligibility for entry prior to making travel plans. More information is available from the following URL: https://safetravel.ica.gov.sg/arriving/overview

From May 4, 2021, foreign nationals who have visited any of the following countries or regions within 14 days of their arrival in the United States are prohibited from entering: Austria, Belgium, Brazil, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Mainland China, Malta, Monaco, Netherlands, Norway, Poland, Portugal, San Marino, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Vatican City, and the United Kingdom. This policy provides limited exemptions for persons providing vital support for critical infrastructure, journalists, students, and certain academics covered by exchange visitor programs.

All persons traveling to the United States (including US nationals) must present proof of a negative result for COVID-19 issued no more than 3 days to departure using a nucleic acid or antigen test. Alternatively, persons who, at any point within 90 days of their scheduled departure for the United States, tested positive for COVID-19 may present "documentation of recovery" for travel to the United States. This must include proof of the positive test result along with a certificate from a recognized healthcare provider attesting that the traveler is not currently exhibiting symptoms consistent with COVID-19 is and cleared for travel. All travelers must additionally sign a form attesting that the information provided to airline staff is truthful and accurate to the best of the traveler's knowledge. Persons lacking such proof are prohibited from boarding flights bound for the United States. More information including post-travel recommendations is available via the following URL: https://www.cdc.gov/coronavirus/2019-ncov/travelers/testing-international-air-travelers.html

The United States government has mostly suspended the issuing of new visas and all US land border checkpoints with Canada and Mexico are closed to non-essential traffic. Additional restrictions are in place for persons holding special category visas including H-1B, H-2B, J-1, and L-1 visas. All travelers are encouraged to contact their local US embassy or consulate prior to finalizing travel arrangements. When arriving into or traveling within the United States, all persons must wear masks covering their mouth and nose while aboard any conveyance or at any transportation hub. Be advised, various state and local authorities in the United States have implemented additional policies and restrictions for persons arriving into their jurisdictions.

From May 4, 2021, foreign nationals who have visited any of the following countries or regions within 14 days of their arrival in the United States are prohibited from entering: Austria, Belgium, Brazil, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Mainland China, Malta, Monaco, Netherlands, Norway, Poland, Portugal, San Marino, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Vatican City, and the United Kingdom. This policy provides limited exemptions for persons providing vital support for critical infrastructure, journalists, students, and certain academics covered by exchange visitor programs.

All persons traveling to the United States (including US nationals) must present proof of a negative result for COVID-19 issued no more than 3 days to departure using a nucleic acid or antigen test. Alternatively, persons who, at any point within 90 days of their scheduled departure for the United States, tested positive for COVID-19 may present "documentation of recovery" for travel to the United States. This must include proof of the positive test result along with a certificate from a recognized healthcare provider attesting that the traveler is not currently exhibiting symptoms consistent with COVID-19 is and cleared for travel. All travelers must additionally sign a form attesting that the information provided to airline staff is truthful and accurate to the best of the traveler's knowledge. Persons lacking such proof are prohibited from boarding flights bound for the United States. More information including post-travel recommendations is available via the following URL: https://www.cdc.gov/coronavirus/2019-ncov/travelers/testing-international-air-travelers.html

The United States government has mostly suspended the issuing of new visas and all US land border checkpoints with Canada and Mexico are closed to non-essential traffic. Additional restrictions are in place for persons holding special category visas including H-1B, H-2B, J-1, and L-1 visas. All travelers are encouraged to contact their local US embassy or consulate prior to finalizing travel arrangements. When arriving into or traveling within the United States, all persons must wear masks covering their mouth and nose while aboard any conveyance or at any transportation hub. Be advised, various state and local authorities in the United States have implemented additional policies and restrictions for persons arriving into their jurisdictions.

Hong Kong SAR residents returning from Macau SAR or Mainland China may be eligible for special quarantine-free entry under the so-called "Return2hk Scheme." Residents must make a reservation online and receive confirmation prior to departure. The daily limit on returnees via the Shenzhen Bay Port is 3,000, the daily limit via the Hong Kong-Zhuhai-Macau Bridge is 2,000, and the daily limit via Hong Kong International Airport is 1,000. All reservations are allocated on a first-come, first-served basis and are non-transferable. Residents seeking to use the Return2hk Scheme must obtain proof of a negative result for COVID-19 issued no more than 72 hours prior to departure using a reverse transcription polymerase chain reaction (RT-PCR) test performed by a testing provider recognized by the HKSAR government. Upon arrival at the boundary control point, residents traveling under the Return2hk Scheme must present a valid Hong Kong SAR Identity Card, a Return2hk reservation confirmation, and proof of a negative RT-PCR test result. Additional information is available at the following URL: https://www.coronavirus.gov.hk/eng/return2hk-scheme.html

All persons arriving at Hong Kong International Airport who are not exhibiting symptoms will be taken to a designated location and tested for COVID-19. All persons are required to wait onsite for their test results. Those who test negative will be instructed on how to proceed directly to their homes or a designated quarantine facility where they must complete their mandatory 14-day or 21-day quarantine.

1) Persons necessary for the supply of goods or services required for the normal operation of Hong Kong SAR or the daily needs of the people of Hong Kong SAR; 

2) Persons necessary for governmental operation;

3) Persons necessary to protect the health or safety of the people of Hong Kong SAR or to handle the public health emergency;

4) Persons receiving nursery, kindergarten, primary, or secondary education at any school registered under the Education Ordinance (Cap. 279) in Hong Kong SAR, persons providing such education, or persons necessary for the safe travelling of any persons arriving in Hong Kong SAR for the purposes outlined in this clause;

5) Persons whose entry is deemed to serve the public interest of Hong Kong SAR; or

6) Persons traveling for purposes relating to manufacturing operations, business activities, or the provision of professional services deemed to be in the interest of economic development in Hong Kong SAR.

1) Persons necessary for the supply of goods or services required for the normal operation of Hong Kong SAR or the daily needs of the people of Hong Kong SAR;

2) Persons necessary for governmental operation;

3) Persons necessary to protect the health or safety of the people of Hong Kong SAR or to handle the public health emergency; or

4) Persons whose entry is deemed to serve the public interest of Hong Kong SAR.

From May 4, 2021, foreign nationals who have visited any of the following countries or regions within 14 days of their arrival in the United States are prohibited from entering: Austria, Belgium, Brazil, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Mainland China, Malta, Monaco, Netherlands, Norway, Poland, Portugal, San Marino, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Vatican City, and the United Kingdom. This policy provides limited exemptions for persons providing vital support for critical infrastructure, journalists, students, and certain academics covered by exchange visitor programs.

All persons traveling to the United States (including US nationals) must present proof of a negative result for COVID-19 issued no more than 3 days to departure using a nucleic acid or antigen test. Alternatively, persons who, at any point within 90 days of their scheduled departure for the United States, tested positive for COVID-19 may present "documentation of recovery" for travel to the United States. This must include proof of the positive test result along with a certificate from a recognized healthcare provider attesting that the traveler is not currently exhibiting symptoms consistent with COVID-19 is and cleared for travel. All travelers must additionally sign a form attesting that the information provided to airline staff is truthful and accurate to the best of the traveler's knowledge. Persons lacking such proof are prohibited from boarding flights bound for the United States. More information including post-travel recommendations is available via the following URL: https://www.cdc.gov/coronavirus/2019-ncov/travelers/testing-international-air-travelers.html

The United States government has mostly suspended the issuing of new visas and all US land border checkpoints with Canada and Mexico are closed to non-essential traffic. Additional restrictions are in place for persons holding special category visas including H-1B, H-2B, J-1, and L-1 visas. All travelers are encouraged to contact their local US embassy or consulate prior to finalizing travel arrangements. When arriving into or traveling within the United States, all persons must wear masks covering their mouth and nose while aboard any conveyance or at any transportation hub. Be advised, various state and local authorities in the United States have implemented additional policies and restrictions for persons arriving into their jurisdictions.

Foreign nationals are prohibited from entering India for tourism. This policy does not apply to Bhutanese and Nepalese nationals. Foreign nationals seeking to travel to India must hold a valid entry visa. All persons holding a previously-issued visa are advised to verify their visa status with a local Indian embassy or consulate prior to making travel arrangements. Persons seeking to travel to India for family emergencies should apply for authorization at an Indian embassy or consulate abroad, which will evaluate applications on a case-by-case basis.

All persons (including Indian nationals and transit passengers) must use the "Air Suvidha" system to submit an online health declaration form and proof of a negative result for COVID-19 issued no more than 72 hours prior to departure using a reverse transcription polymerase chain reaction (RT-PCR) test. Travelers must further agree to abide by all regulations concerning quarantine and self-isolation issued by appropriate Indian government authorities. All persons must monitor their health status for 14 days following arrival in India. Travelers arriving on flights originating in Europe (including the United Kingdom) or the Middle East must undergo testing for COVID-19 upon arrival. All persons traveling aboard flights originating in Brazil, South Africa, or the United Kingdom must self-isolate for 7 days, undergo an additional test for COVID-19 following the self-isolation period, and monitor their health status for a further 7 days. Persons who at any point test positive for COVID-19 will be isolated and sent for treatment. All persons are advised to install the "Aarogya Setu" mobile application for contact tracing purposes. Health declaration forms are available at the following URL: https://www.newdelhiairport.in/airsuvidha/apho-registration

Be advised, some state-level authorities in India have implemented additional policies and restrictions for persons arriving into their jurisdictions. More information on current national guidelines is available at the following URI: https://www.mohfw.gov.in/pdf/Guidelinesforinternationalarrivals17022021.pdf

From May 4, 2021, foreign nationals who have visited any of the following countries or regions within 14 days of their arrival in the United States are prohibited from entering: Austria, Belgium, Brazil, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Mainland China, Malta, Monaco, Netherlands, Norway, Poland, Portugal, San Marino, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Vatican City, and the United Kingdom. This policy provides limited exemptions for persons providing vital support for critical infrastructure, journalists, students, and certain academics covered by exchange visitor programs.

All persons traveling to the United States (including US nationals) must present proof of a negative result for COVID-19 issued no more than 3 days to departure using a nucleic acid or antigen test. Alternatively, persons who, at any point within 90 days of their scheduled departure for the United States, tested positive for COVID-19 may present "documentation of recovery" for travel to the United States. This must include proof of the positive test result along with a certificate from a recognized healthcare provider attesting that the traveler is not currently exhibiting symptoms consistent with COVID-19 is and cleared for travel. All travelers must additionally sign a form attesting that the information provided to airline staff is truthful and accurate to the best of the traveler's knowledge. Persons lacking such proof are prohibited from boarding flights bound for the United States. More information including post-travel recommendations is available via the following URL: https://www.cdc.gov/coronavirus/2019-ncov/travelers/testing-international-air-travelers.html

The United States government has mostly suspended the issuing of new visas and all US land border checkpoints with Canada and Mexico are closed to non-essential traffic. Additional restrictions are in place for persons holding special category visas including H-1B, H-2B, J-1, and L-1 visas. All travelers are encouraged to contact their local US embassy or consulate prior to finalizing travel arrangements. When arriving into or traveling within the United States, all persons must wear masks covering their mouth and nose while aboard any conveyance or at any transportation hub. Be advised, various state and local authorities in the United States have implemented additional policies and restrictions for persons arriving into their jurisdictions.